Medical device licence · 2871 · Class 2
LEUCINE ARYLAMIDASE (LAP)
No longer licensed: discontinued at renewal
Licence status Discontinued at renewal; first licensed May 13, 1999; ended April 16, 2004. It is in Health Canada’s archive of licences no longer in force.
- Licence number
- 2871
- Licence holder
- Roche Diagnostics GmbhMannheim, Germany
- Risk class
- Class II (low to moderate risk)
- Licence type
- Device Family
- First licensed
- May 13, 1999
- Ended
- April 16, 2004
- Devices covered
- 2
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- LEUCINE ARYLAMIDASE
- LEUCINE ARYLAMIDASE
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.